HIRONIC

Hironic Inc. (CEO Jinwoo Lee), a leading aesthetic medical device company, announced on the 24th that it has signed new export contracts with distributors in Singapore and Malaysia. This comes just two weeks after securing a major KRW 48.4 billion (approx. USD 35.5 million) supply agreement for its SYNERJET device in the North American market. According to a company official, “We recently signed agreements with key Asian distributors to export our flagship devices, including NEW DOUBLO 2.0 and SYNERJET. We aim to diversify our sales channels throughout Asia and increase our export ratio.” Hironic is actively expanding its supply chain to accelerate sales recovery in Asia. The company has completed construction of its second and third manufacturing plants in Osong, Chungbuk Province, enhancing its production infrastructure. This expansion is expected to improve manufacturing efficiency and ensure a stable global supply to meet rising overseas demand. The company also aims to facilitate the resumption of stock trading by demonstrating robust operational capabilities. SYNERJET, Hironic’s core product, utilizes a combination of Microjetting, Plasma, and Electroporation technologies to deliver skin booster ingredients without the use of needles. It offers the advantage of reduced pain and minimal downtime, making it highly attractive in both Asian and Western aesthetic markets. Previously, on November 10, Hironic signed a conditional supply agreement with a North American medical device distributor worth KRW 48.4 billion, approximately 1.5 times the company’s 2024 annual revenue of KRW 31.6 billion. The contract runs through October 2030 and is contingent upon obtaining U.S. FDA and Canada MDEL approvals. The company anticipates FDA clearance in the first half of next year. Under the agreement, 50% of the payment is made at the time of order, with the remaining 50% prior to shipment. Hironic is now at a pivotal point in its global expansion, driven by strategic partnerships across Asia and North America. Key challenges ahead include timely regulatory approvals, activation of local sales networks, and brand-building efforts in new international markets.​ 

Hironic Inc. (CEO Jinwoo Lee), a leading manufacturer of aesthetic medical devices, announced on the 10th that it has signed a conditional supply agreement worth KRW 48.4 billion (approx. USD 35.5 million) with a newly contracted distributor for the North American market, including the United States and Canada, for its flagship product 'SYNERJET.' The agreement runs until October 8, 2030, and the total contract value represents approximately 153% of Hironic’s 2024 revenue of KRW 31.6 billion. Under the contract, 50% of the payment will be made upon order and the remaining 50% prior to shipment. The deal is conditional upon the successful acquisition of U.S. FDA and Canadian MDEL approvals, expected around April 2026. The estimated contract amount is based on the distributor's projected sales volume post-approval. SYNERJET is a needle-free injector that combines Microjetting, Plasma, and Electroporation technologies to deliver active ingredients into the skin without needles. The device is designed to minimize pain and downtime compared to conventional needle-based procedures, making it a highly appealing option in the aesthetic dermatology market. A Hironic official stated, “This marks our first contract with this North American distributor and serves as a significant milestone in our efforts to penetrate the U.S. market. We plan to actively support certification procedures and develop tailored marketing strategies in line with global expansion goals.” Hironic is currently exporting to over 50 countries worldwide and has a diverse portfolio of advanced aesthetic devices, including PICOHI, DOUBLO GOLD, and V-RO. The company is strengthening its global footprint through new branch establishments and regulatory approvals in major markets such as the U.S., Europe, and Japan.​ 

SEOUL, Korea – November 1, 2025 – Hironic (CEO Jinwoo Lee), a global leader in aesthetic and medical devices, announced that it successfully held a hands-on seminar on November 1 at OgaYe Clinic, presenting its signature technologies, SYNERJET and V-RO Lifting (Export Name: New Doublo 2.0), to an audience of international healthcare professionals. This seminar aimed to share Hironic’s technological advancements and clinical expertise while providing global medical professionals an opportunity to explore practical applications of the devices. Attendees from diverse countries actively engaged in Q&A sessions, reflecting keen interest in the equipment. Dr. Jia Seok of OgaYe Clinic led the session, delivering an in-depth presentation on the mechanism, clinical utilization, and procedural strategies of the devices. Drawing from her extensive clinical experience, Dr. Seok’s lecture generated vibrant discussions and real-time insights, offering practical knowledge such as device settings and treatment tips, which were well-received. SYNERJET, a needle-free injector that uses microjet technology for rapid and even delivery of skin boosters, garnered strong attention for its efficacy and patient comfort. The subsequent session on V-RO Lifting (Export Name: New Doublo 2.0), a dual-energy system combining High-Intensity Focused Ultrasound (HIFU) and Radio Frequency (RF), captivated the audience with its adaptability across varying skin conditions. This event not only highlighted the capabilities of Korean medical aesthetics but also underscored its role in shaping global treatment standards. International attendees expressed enthusiasm about applying these innovations in their local markets, marking the seminar as a meaningful step in the globalization of Korea’s medical device industry. A Hironic representative commented, “The seminar was a valuable opportunity to demonstrate the excellence of our devices directly to global healthcare professionals,” adding, “We will continue to expand our global footprint through international seminars and KOL (Key Opinion Leader) collaborations.”​ 

Seoul, South Korea – October 18, 2025 – HIRONIC Co., Ltd., a global leader in aesthetic and medical device innovation, announced the successful conclusion of its “SYNERJET X K BOOSTER Masterclass Seminar,” held on October 18. Led by Dr. Sangsoo Lee (Mirabel Clinic) and Dr. Sanghyuk Kim (Grandmedi Clinic), the event showcased best practices in delivering tailored solutions using HIRONIC’s needle-free microjet device SYNERJET in combination with K BOOSTER, a high-functionality aesthetic derma brand. The speakers shared clinical know-how based on real-world applications and synergy-driven outcomes. A key highlight of the seminar was the “K BOOSTER SHOWER” protocol—a needle-free, painless absorption method that uses SYNERJET to deliver K BOOSTER PDRN Plus Ampoule deep into the skin. This next-generation skin booster solution drew significant attention from attending medical professionals for its effectiveness and patient comfort. Developed by HIRONIC, SYNERJET is designed to deliver active ingredients through microjet spray technology without the use of needles. Its compatibility with a wide range of skin booster formulations makes it a versatile device for various clinical applications, enhancing both practitioner convenience and patient satisfaction. K BOOSTER, known for its ECM (extracellular matrix)-based active ingredients, has gained strong traction across dermatology clinics and the home care market. When paired with SYNERJET, the ampoules demonstrate enhanced absorption rates and user satisfaction. “This seminar was more than a product demonstration—it was an opportunity to validate a comprehensive solution that benefits both practitioners and patients,” said a HIRONIC spokesperson. “We will continue to build new standards in aesthetic medicine by expanding collaborations centered around SYNERJET.” The event also included live device demonstrations and hands-on sessions, helping attendees gain practical insights into skin and scalp care techniques. HIRONIC continues to lead in the aesthetic medical field by combining innovation and clinical collaboration. The company aims to foster global growth through advanced technologies and strategic partnerships.​ 

Seoul, South Korea – October 13, 2025 – HIRONIC Inc. (CEO: Jinwoo Lee), a leading manufacturer of aesthetic medical devices, announced the successful completion of its ‘SYNERJET Hands-On Seminar’ held on September 30 at Classone Clinic in Seoul. The seminar aimed to deepen medical professionals’ understanding of SYNERJET and to foster clinical knowledge exchange. Reflecting the high interest in HIRONIC’s needle-free microjet technology, the event featured in-depth lectures and live demonstrations, followed by a dynamic Q&A session filled with active discussions. SYNERJET is a non-invasive device that delivers active ingredients into the skin using a high-pressure jet injection system. By eliminating the need for needles, the device minimizes pain, bruising, and bleeding while maximizing absorption efficiency—aligning perfectly with the current trend in aesthetic medicine that emphasizes both safety and efficacy. The device was met with favorable feedback from attending physicians. A HIRONIC spokesperson commented, “The seminar reaffirmed the strong interest of clinical professionals in our SYNERJET technology,” and added, “We will continue engaging with medical professionals across various regions through localized seminars, building mutual trust and reinforcing our clinical partnerships.”​ 

Seoul, Korea – As aesthetic treatments become increasingly mainstream, demand for skin boosters and injection-based procedures continues to grow. In this evolving landscape, the aesthetic medicine field is turning its focus from merely achieving visible results to prioritizing safety and procedure consistency. Notably, needle-free technology has emerged as a compelling alternative, gaining traction among both practitioners and patients. This needle-free approach minimizes the psychological burden of needles for patients and enables more consistent delivery of active ingredients—regardless of the operator’s level of experience. It reduces variability in results and enhances both comfort and procedural safety, opening new frontiers in aesthetic innovation. Recently, devices utilizing needle-free microjet technology have expanded the options for skin booster applications. Among them, SYNERJET, developed by Hironic, uses a high-velocity microjet stream to deliver active substances into the skin in a completely non-invasive way. Because it does not puncture the skin, it significantly reduces the likelihood of pain, bruising, and serious vascular complications. Dr. Kim Min-cheol, Medical Director of Haoderm Clinic, commented, “Traditional needle-based procedures may lead to side effects depending on the practitioner's skill level. Patients also express concerns about pain and complications.” He added, “The market is now moving towards evaluating treatments holistically—combining visible efficacy with patient experience and procedural safety.” Dr. Kim further emphasized his clinic’s philosophy: “We strive for skin that improves every day—a better tomorrow starts today. It's our role to help patients feel that the moment they step out of our clinic.” He concluded, “The needle-free microjet method alleviates the fear associated with needle injections while enabling healthcare providers to deliver active ingredients more safely and effectively. This is not just about following trends—it’s a clinically validated, high-value technology with sustainable benefits.”​ 

HIRONIC Co., Ltd. (CEO Jinwoo Lee), a leading medical aesthetic device manufacturer, announced the successful completion of its ‘V-RO Lifting (export name: New Doublo 2.0) Hands-on Seminar’ held recently in Busan, South Korea. The seminar was designed to enhance the clinical proficiency of medical professionals in the southeastern region through comprehensive training programs featuring HIRONIC’s flagship HIFU (High-Intensity Focused Ultrasound) device, ‘V-RO Lifting (New Doublo 2.0)’, and Microneedle RF technology. Dr. Hyejung Cha of Areumdawoon Clinic led the seminar with both theoretical lectures and live demonstrations on combined treatments using HIFU, RF, and Microneedle RF technologies—receiving enthusiastic feedback from participants. V-RO Lifting (New Doublo 2.0) is a next-generation lifting device that integrates HIFU and RF energies, offering precise targeting and a versatile range of cartridges to support various clinical applications. “V-RO’s dual-energy system allows for enhanced lifting effects while improving pores, skin elasticity, and texture—all with a single device,” said Dr. Cha. “This seminar was valuable in sharing practical know-how that can be directly applied in real-world clinical settings.” She further commented, “The newly released SYNERJET, based on micro-jet technology, also shows great promise for treating scars and pigmentation issues. It’s expected to significantly expand our clinical indications.” A HIRONIC spokesperson stated, “V-RO offers precision energy control and a versatile configuration for combination treatments, making it an ideal solution for diverse clinical needs. We will continue to strengthen customer understanding and trust through region-specific seminars.”​ 

HIRONIC Inc. (CEO Jinwoo Lee), a leading medical aesthetics device manufacturer, announced the successful completion of its “SILKRO Seminar” held last month in Istanbul, Türkiye, in partnership with its local distributor, Nora Medikal. The seminar gathered around 80 local dermatologists, including current and potential users of SILKRO​, highlighting the device's advanced features and clinical efficacy. The event served as a platform to share real-world clinical experiences and treatment outcomes, drawing strong interest from the attending medical professionals. Key sessions of the seminar focused on the unique functionalities of SILKRO​, treatment protocols using various handpieces, and data-driven clinical outcomes. In particular, a presentation comparing the combined use of the RM and PS handpieces with competitor devices in terms of both technology and design excellence received enthusiastic attention from participants. Live demonstrations using the microneedling and plasma handpieces simulated real clinical settings, offering hands-on insights into practical device usage and treatment protocols. Detailed discussions on country-specific treatment trends and handpiece combinations provided valuable guidance and sparked engaging dialogue among attendees. A HIRONIC spokesperson commented, “The local dermatologists expressed high confidence in the safety and effectiveness of our devices. Active interaction between speakers and the audience helped strengthen both brand awareness and trust.” HIRONIC also shared its strategy to further solidify its presence in Türkiye and across Europe by expanding localized marketing efforts and continuing clinical-driven promotional activities.​ 

HIRONIC Inc. (CEO Jinwoo Lee), a leading manufacturer of medical aesthetic devices, has launched “SYNERJET,” a needle-free microjet system designed to reduce pain and post-procedural discomfort in aesthetic treatments. The device delivers active ingredients into the skin using high-pressure micro air streams, offering patients a less invasive alternative to traditional injections. The development of SYNERJET addresses growing concerns among patients about the pain and bruising commonly associated with needle-based treatments. By utilizing a combination of needle-free microjet diffusion, plasma, and electroporation technology, SYNERJET enhances skin absorption while minimizing tissue trauma. This technology is gaining attention for its ability to improve recovery comfort and deliver more complete rejuvenation outcomes. Dr. Byungwook Kim, Chief Director of Seoul All-Up Dermatology Clinic, stated in a recent interview, “Demand is rapidly increasing in the aesthetic market for solutions that reduce pain and recovery time. The needle-free microjet technology is a promising response to these evolving expectations.” He added, “While traditional injection methods may vary in discomfort depending on practitioner skill, SYNERJET offers shorter treatment times and lower pain levels, resulting in higher patient satisfaction.” Experts believe this needle-free approach could serve as a suitable option for patients with needle anxiety or those requiring minimal downtime post-treatment. However, they also emphasize the importance of consulting medical professionals, as effectiveness may vary based on individual skin conditions and indications.​ 

Hironic Inc. (CEO: Jinwoo Lee) announced on August 21 that it has received official medical device sales approval from the Taiwan Food and Drug Administration (TFDA) for its integrated lifting system ‘New Doublo 2.0’. The company also confirmed that Collamatrix, a top-tier distributor in Taiwan, will serve as its exclusive partner in the region. The aesthetic medical device industry is currently experiencing rapid growth driven by technological convergence and increasing preference for non-invasive procedures. According to global market research, the global aesthetic medicine market is expected to reach USD 71.62 billion by 2025, with a CAGR of 7.75%. Taiwan’s market is also expanding steadily due to its aging population and evolving beauty trends. Industry analysts forecast the Taiwanese beauty and personal care market to reach approximately USD 5.7 billion by 2027. Hironic’s expansion into Taiwan is backed by growing regional demand for advanced hybrid technologies such as HIFU (High-Intensity Focused Ultrasound) and RF (Radio Frequency). The ‘New Doublo 2.0’ combines HIFU, RF, and microneedling capabilities, offering powerful lifting results with shorter treatment time and minimal recovery burden. Taiwanese dermatologists who attended the 2024 Taiwan Symposium highlighted the device’s “multi-layer treatment advantage” and anticipated broad patient adoption. Hironic views this regulatory milestone not merely as a sales license, but as a significant example of how K-Beauty is extending beyond cosmetics into high-value medical aesthetics. The company believes the Korean aesthetic medical device sector is proving its global competitiveness in both technology and compliance. “Hironic aims to elevate its brand value in Taiwan to the highest tier,” said Sungho Lee​, Chief Marketing Officer at Hironic. “We expect the standardization and global brand power of Korean medical aesthetic devices to grow even stronger in the coming years.”​ 

SEOUL, South Korea – August 21, 2025 – HIRONIC Inc. (CEO: Jinwoo Lee), a leading manufacturer of aesthetic medical devices, announced that its advanced synergy device ‘New Doublo 2.0’ has received certification from the Indonesian Ministry of Health (KEMENKES RI). This certification marks an official entry point into one of Southeast Asia’s fastest-growing beauty device markets. Indonesia, with a population of over 270 million, is the region’s largest market and is experiencing rapid growth in its middle class. As a result, demand for non-invasive aesthetic treatments and premium devices continues to rise, with the country's medical aesthetic device market expanding at an annual growth rate of 11.5%. ‘New Doublo 2.0’ is a multifunctional platform combining HIFU (High-Intensity Focused Ultrasound), RF (Radio Frequency), and Micro-Needling technologies in one system. This enables clinics to offer diverse skin lifting and tightening procedures with a single device—meeting the growing demand for high-performance, multi-modality solutions in aesthetic practices. The Indonesian market’s increasing preference for advanced, non-invasive lifting procedures aligns with the value proposition of New Doublo 2.0. By delivering enhanced results and treatment flexibility, the device addresses local customer needs and supports clinics’ efforts to differentiate their services through premium technologies. CMO Sungho Lee commented, “Indonesia is witnessing a surge in demand for aesthetic devices based on multi-energy platforms. New Doublo 2.0, inheriting the legacy of our globally recognized Doublo series, is uniquely positioned to lead this market. We aim to strengthen our footprint in Indonesia and drive global revenue growth through this differentiated innovation.” Following this certification, HIRONIC plans to focus its market penetration strategy on premium clinics in major Indonesian cities, positioning ‘New Doublo 2.0’ as a top-tier solution for lifting and complex skin treatments. The company also aims to expedite certifications across other Southeast Asian nations. Additionally, HIRONIC is set to launch the ‘SYNERJET PRO,’ a next-generation skin booster injector, as part of its broader strategy to reinforce its leadership in the aesthetic medical device industry through continuous technological innovation.​ 

As the global influence of K-beauty continues to rise, technological advancements in the aesthetic medical field are accelerating. In particular, innovative treatment methods that enhance patient comfort are drawing increasing attention. Among them, skin booster treatments—known for improving hydration, elasticity, and skin texture—are rapidly gaining popularity and setting new trends. Skin booster procedures restore skin health and beauty by delivering various active ingredients directly into the skin. Traditionally, these treatments relied on needles, which could cause pain, bruising, and swelling, resulting in concerns about recovery time for some patients. Recently, new techniques have emerged to address these limitations, offering a broader range of treatment options. One standout innovation is the “Needle-Free” method, which minimizes pain and downtime. The needle-free approach uses Micro Jet technology to deliver active ingredients deep into the dermis using high-pressure microscopic jets—without the need for needles. This method reduces discomfort during treatment, shortens recovery time, and enhances skin absorption efficiency. Moreover, devices that combine Micro Jet technology with low-temperature plasma and electroporation are also entering the market. A prime example is SYNERJET by Hironic, which enhances skin rejuvenation effects while reducing pain, providing patients with a more comfortable experience. Dr. Hyejeong Cha, Director of Beautiful Clinic, remarked, “I’m always interested in trying new technologies. Recently, patients have shown growing concern for both safety and comfort. The needle-free delivery method lowers the psychological barrier to injections, offering a new paradigm for skin rejuvenation and anti-aging without the burden of pain.” However, those considering this treatment should consult with experienced medical professionals to receive an accurate diagnosis and ensure personalized care based on their skin condition. After the procedure, it is essential to follow post-treatment guidelines provided by medical staff, including proper moisturization and UV protection, to maintain results and prevent side effects.​ 

Seoul, South Korea – August 11, 2025 – HIRONIC Inc. (KOSDAQ: 149980), a global manufacturer of innovative aesthetic medical devices, announced growing interest in its needle-free skin booster device SYNERJET, which minimizes treatment pain and recovery time while maximizing active ingredient absorption for skin rejuvenation. Summer skin is often exposed to intense UV rays and hot, humid conditions, which can weaken the skin barrier, accelerate collagen damage, and lead to visible signs of aging such as fine lines, enlarged pores, and loss of elasticity. While daily protection through sunblock and hydration is essential, more advanced solutions are increasingly in demand for those already experiencing skin damage or early signs of aging. Among the popular options, skin booster treatments have gained attention for directly delivering beneficial active ingredients into the skin, improving hydration, elasticity, fine lines, and overall skin tone. Traditionally, these treatments involve needle injections, which can cause discomfort and deter some patients from seeking care. SYNERJET addresses this concern by replacing needles with a high-pressure microjet delivery system, allowing active ingredients to penetrate the skin evenly and deeply with minimal pain. Its integration of plasma and electroporation technology further enhances permeability and stimulates the skin’s natural regeneration process, providing a more complete rejuvenation experience. Dr. Nam Hyun-seok, Medical Director of Shine Beam Clinic Songdo, commented: “By combining plasma, microjet, and electroporation, SYNERJET significantly improves absorption of active ingredients, supporting fundamental skin regeneration. The needle-free approach also greatly reduces pain and downtime, which translates into high patient satisfaction.”  Consumers considering a skin booster procedure are advised to consult with qualified medical professionals to determine the most suitable treatment for their skin condition and goals. Choosing clinics equipped with certified devices and a safe treatment environment, along with following pre- and post-care instructions, is essential for optimal results.​ 

Seoul, Korea – HIRONIC Co., Ltd. (CEO Jinwoo Lee), a leading medical aesthetic device manufacturer, announced that it successfully held the ‘SYNERJET x Classone Clinic Hands-on Seminar’ on the evening of July 29 at Classone Clinic in Gangnam, Seoul. This seminar was organized to share practical application methods and usage insights of HIRONIC’s latest device, ‘SYNERJET’, which is based on advanced micro-jet injection technology. Participants had the opportunity to experience the technical features and treatment efficiency of the device through a curriculum aligned with the latest clinical trends. Dr. Wonkyu Hong of Classone Clinic, the keynote speaker of the seminar, delivered a live lecture and hands-on session on the theme “Application of GOURI Skin Booster Using SYNERJET,” demonstrating real patient cases. He commented, “SYNERJET offers stable energy delivery tailored to various skin conditions, allowing for flexible treatment design and reliable outcomes.” Despite being held in the evening, the seminar attracted a significant number of medical professionals and was conducted in a dynamic and engaging atmosphere. A post-event satisfaction survey revealed positive feedback such as, “The content was highly practical and informative,” and “The clinical approach was especially impressive.” A HIRONIC official stated, “We plan to continue expanding hands-on seminars to enhance the practical utility of SYNERJET and other flagship devices,” and added, “By closely collaborating with KOLs (Key Opinion Leaders), we aim to strengthen education-driven marketing efforts.”​ 

As strong UV rays and high temperatures in summer intensify skin concerns, interest in non-invasive procedures offering convenient and effective skincare is growing. In particular, skin booster treatments are garnering high preference due to their variety of delivery methods and enhanced convenience. Medical professionals are increasingly adopting techniques that minimize patient discomfort. Dr. Jinseob Lee, Director of Lavie Dermatology Clinic, commented, “In dermatological care, patient satisfaction is the most crucial value, which ultimately fosters trust between medical staff and patients. Recent advancements in technology have brought attention to needle-free procedures that can be administered comfortably.” He emphasized that “this reflects a broader trend where the quality of the treatment experience, not just the outcome, is now a key factor.”As treatment experience becomes a central value, the development of various non-invasive techniques is accelerating. Among these innovations, technologies that minimize or eliminate the use of needles are gaining attention. One such approach is based on microjet technology. A leading example is the device ‘SYNERJET,’ which uses plasma to gently open the skin surface and combines high-pressure jet injection with electroporation to enable even absorption of active ingredients into the skin. Notably, this needle-free treatment is especially advantageous for patients with sensitive skin. Dr. Lee explained the benefits of this technological shift: “The microjet method significantly reduces pain during treatment, alleviating patient anxiety. It also shortens treatment time, making it efficient for busy individuals. Moreover, the uniform absorption of active ingredients leads to improved skin regeneration and elasticity.” However, Dr. Lee advised that even non-invasive procedures require a thorough pre-treatment assessment of individual skin conditions, medical history, and any pre-existing conditions. “To achieve satisfactory results, it is crucial to consult with skilled medical professionals, determine the most suitable treatment plan, and strictly adhere to pre- and post-treatment care guidelines. This ensures minimized side effects and maximized efficacy,” he concluded.​